Ionis Pharmaceuticals, Inc.’s Post

Seth Baum M.D., MASPC, FACC, FAHA, FNLA shares what the availability of a new treatment means to the FCS community. Learn more: https://lnkd.in/eg2G4NpH

  • No alternative text description for this image
Richard Geary

Executive Vice President, Drug Development at Ionis Pharmaceuticals, Inc.

6d

Thanks for sharing Seth. Thank you for all your support in bringing this medicine to patients!

Like
Reply

To view or add a comment, sign in

Explore topics